✦ LIBER ✦

Characterisation of biomolecular profiles in primary high-grade prostate cancer treated by radical prostatectomy

✍ Scribed by Herbert Augustin; PeterG. Hammerer; Markus Graefen; Jüri Palisaar; Fedor Daghofer; Hartwig Huland; Andreas Erbersdobler

Publisher: Springer-Verlag
Year: 2003
Tongue: English
Weight: 844 KB
Volume: 129
Category: Article
ISSN: 1432-1335
DOI: 10.1007/s00432-003-0496-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Substratification of high-risk localised

Substratification of high-risk localised prostate cancer treated by radical prostatectomy

✍ Michele Lodde; François Harel; Louis Lacombe; Yves Fradet 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 268 KB

Ki67 LABELLING INDEX: AN INDEPENDENT PRE

Ki67 LABELLING INDEX: AN INDEPENDENT PREDICTOR OF PROGRESSION IN PROSTATE CANCER TREATED BY RADICAL PROSTATECTOMY

✍ BUBENDORF, LUKAS; SAUTER, GUIDO; MOCH, HOLGER; SCHMID, HANS-PETER; GASSER, THOMA 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 607 KB

The clinical course of prostate cancer is highly variable and cannot satisfactorily be predicted by histological criteria alone. Both tumour cell proliferation and neuroendocrine differentiation have been suggested as additional prognostic parameters, neuroendocrine differentiation being considered

Atrophy in specimens of radical prostate

Atrophy in specimens of radical prostatectomy: is there topographic relation to high-grade prostatic intraepithelial neoplasia or cancer?

✍ Antonio A. Brasil; Wagner J. Favaro; Valeria H. Cagnon; Ubirajara Ferreira; Atha 📂 Article 📅 2010 🏛 Springer Netherlands 🌐 English ⚖ 406 KB

Circulating estradiol, but not testoster

Circulating estradiol, but not testosterone, is a significant predictor of high-grade prostate cancer in patients undergoing radical prostatectomy

✍ Andrea Salonia; Andrea Gallina; Alberto Briganti; Nazareno Suardi; Umberto Capit 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 1 views

The prognostic influence of neuroendocri

The prognostic influence of neuroendocrine cells in prostate cancer: Results of a long-term follow-up study with patients treated by radical prostatectomy

✍ Marinus A. Noordzij; Theodorus H. Van Der Kwast; Gert Jan Van Steenbrugge; Wim J 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 726 KB

Phase II trial of neoadjuvant docetaxel

Phase II trial of neoadjuvant docetaxel and gefitinib followed by radical prostatectomy in patients with high-risk, locally advanced prostate cancer

✍ Jacqueline Vuky; Christopher Porter; Christina Isacson; Matthew Vaughan; Paul Ko 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 1 views

## Abstract ## BACKGROUND: Prostate cancer trials investigating neoadjuvant hormonal therapy, followed by surgery, have demonstrated that elimination of all tumor cells from the primary site is rare. The authors report a phase 2 trial assessing the efficacy and toxicity of docetaxel and gefitinib